Combining Heart Rate Variability with Disease Severity Score Variables for Mortality Risk Stratification in Septic Patients Presenting at the Emergency Department.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
16 05 2019
Historique:
received: 16 04 2019
revised: 13 05 2019
accepted: 14 05 2019
entrez: 19 5 2019
pubmed: 19 5 2019
medline: 18 12 2019
Statut: epublish

Résumé

The emergency department (ED) serves as the first point of hospital contact for many septic patients, where risk-stratification would be invaluable. We devised a combination model incorporating demographic, clinical, and heart rate variability (HRV) parameters, alongside individual variables of the Sequential Organ Failure Assessment (SOFA), Acute Physiology and Chronic Health Evaluation II (APACHE II), and Mortality in Emergency Department Sepsis (MEDS) scores for mortality risk-stratification. ED patients fulfilling systemic inflammatory response syndrome criteria were recruited. National Early Warning Score (NEWS), Modified Early Warning Score (MEWS), quick SOFA (qSOFA), SOFA, APACHE II, and MEDS scores were calculated. For the prediction of 30-day in-hospital mortality, combination model performed with an area under the receiver operating characteristic curve of 0.91 (95% confidence interval (CI): 0.88-0.95), outperforming NEWS (0.70, 95% CI: 0.63-0.77), MEWS (0.61, 95% CI 0.53-0.69), qSOFA (0.70, 95% CI 0.63-0.77), SOFA (0.74, 95% CI: 0.67-0.80), APACHE II (0.76, 95% CI: 0.69-0.82), and MEDS scores (0.86, 95% CI: 0.81-0.90). The combination model had an optimal sensitivity and specificity of 91.4% (95% CI: 81.6-96.5%) and 77.9% (95% CI: 72.6-82.4%), respectively. A combination model incorporating clinical, HRV, and disease severity score variables showed superior predictive ability for the mortality risk-stratification of septic patients presenting at the ED.

Identifiants

pubmed: 31100830
pii: ijerph16101725
doi: 10.3390/ijerph16101725
pmc: PMC6571945
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

JAMA. 2010 Oct 27;304(16):1787-94
pubmed: 20978258
QJM. 2001 Oct;94(10):521-6
pubmed: 11588210
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Science. 1991 Oct 18;254(5030):389-94
pubmed: 1925596
Acad Emerg Med. 2007 May;14(5):392-7
pubmed: 17389245
PLoS One. 2019 Mar 18;14(3):e0213445
pubmed: 30883595
Can J Cardiol. 1991 Jun;7(5):207-13
pubmed: 1860092
Ann Intern Med. 2018 Feb 20;168(4):266-275
pubmed: 29404582
Shock. 2019 Apr;51(4):416-422
pubmed: 29847498
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
Physiol Meas. 2002 May;23(2):385-401
pubmed: 12051310
Chest. 2016 May;149(5):1117-8
pubmed: 26927525
Circulation. 1997 Aug 5;96(3):842-8
pubmed: 9264491
Acad Emerg Med. 2002 Jul;9(7):661-70
pubmed: 12093705
PLoS One. 2017 Jun 27;12(6):e0180060
pubmed: 28654692
Crit Care Med. 2003 Mar;31(3):670-5
pubmed: 12626967
Eur Heart J. 1996 Mar;17(3):354-81
pubmed: 8737210
Resuscitation. 2010 Aug;81(8):932-7
pubmed: 20637974
Am J Emerg Med. 2019 Aug;37(8):1490-1497
pubmed: 30470600
Crit Care Med. 2016 Mar;44(3):539-47
pubmed: 26901543
Crit Care Med. 1985 Oct;13(10):818-29
pubmed: 3928249
Front Public Health. 2017 Sep 28;5:258
pubmed: 29034226
Chest. 1992 Jun;101(6):1644-55
pubmed: 1303622
Math Biosci. 2014 Jun;252:36-44
pubmed: 24680646
Circulation. 2000 Jan 4-11;101(1):47-53
pubmed: 10618303
JAMA. 2016 Feb 23;315(8):762-74
pubmed: 26903335
Emerg Med J. 2018 Feb;35(2):96-102
pubmed: 28821492
Am J Respir Crit Care Med. 2016 Feb 1;193(3):259-72
pubmed: 26414292
Eur J Emerg Med. 2015 Oct;22(5):331-7
pubmed: 25144398
Neth J Med. 2018 May;76(4):158-166
pubmed: 29845938
Am J Emerg Med. 2008 May;26(4):395-401
pubmed: 18410805
Crit Care Med. 2009 Apr;37(4):1317-21
pubmed: 19242333
Medicine (Baltimore). 2018 Jun;97(23):e10866
pubmed: 29879021
Acad Emerg Med. 2014 Nov;21(11):1257-63
pubmed: 25377403

Auteurs

Jeremy Zhenwen Pong (JZ)

Duke-NUS Medical School, National University of Singapore, Singapore 169857, Singapore. jeremypong@u.duke.nus.edu.

Stephanie Fook-Chong (S)

Health Services Research Unit, Singapore General Hospital, Singapore 169608, Singapore. stephanie.fook.m.c@sgh.com.sg.

Zhi Xiong Koh (ZX)

Department of Emergency Medicine, Singapore General Hospital, Singapore 169608, Singapore. koh.zhixiong@singhealth.com.sg.

Mas'uud Ibnu Samsudin (MI)

General Medicine, Ministry of Health Holdings, Singapore 099253, Singapore. masuud.ibnusamsudin@mohh.com.sg.

Takashi Tagami (T)

Department of Emergency and Critical Care Medicine, Nippon Medical School Tama Nagayama Hospital, Tokyo 206-8512, Japan. t-tagami@nms.ac.jp.

Calvin J Chiew (CJ)

Preventive Medicine Residency Program, National University Health System, Singapore 119228, Singapore. calvin.chiew@mohh.com.sg.

Ting Hway Wong (TH)

Department of General Surgery, Singapore General Hospital, Singapore 169608, Singapore. wong.ting.hway@singhealth.com.sg.

Andrew Fu Wah Ho (AFW)

Department of Emergency Medicine, Singapore General Hospital, Singapore 169608, Singapore. andrew.ho@mohh.com.sg.

Marcus Eng Hock Ong (MEH)

Duke-NUS Medical School, National University of Singapore, Singapore 169857, Singapore. marcus.ong.e.h@singhealth.com.sg.
Department of Emergency Medicine, Singapore General Hospital, Singapore 169608, Singapore. marcus.ong.e.h@singhealth.com.sg.

Nan Liu (N)

Duke-NUS Medical School, National University of Singapore, Singapore 169857, Singapore. liu.nan@duke-nus.edu.sg.
Health Services Research Centre, Singapore Health Services, Singapore 169856, Singapore. liu.nan@duke-nus.edu.sg.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH